Lobe Sciences Ltd. (CVE:LOBE) | Finanzwire

Basculer en Français

10591	Companies
224581	Keywords
153310	Articles
118794	Press releases

Home
Companies
Lobe Sciences Ltd.

BRIEF

published on 06/09/2026 at 12:05, 8 days 15 hours ago

Lobe Sciences Increases Management Equity Through Share Settlement

Research And Development Clinical Programs Lobe Sciences Subsidiary Model Equity Settlement
PRESS RELEASE

published on 06/09/2026 at 12:00, 8 days 15 hours ago

Lobe Sciences Directors and Management Increase Equity Ownership Through Settlement of Accrued Fees by the Issuance of Common Shares
Lobe Sciences Ltd. settles accrued management fees through issuance of common shares, strengthening ownership alignment with shareholders and maintaining strong financial position with C$4.96 million in cash and short-term investments

Financial Position Share Issuance Clinical-Stage Biopharmaceutical Lobe Sciences Ltd. Subsidiary R&D Programs
BRIEF

published on 06/02/2026 at 04:05, 15 days 23 hours ago

Lobe Sciences to Resolve Debt Through Share Issuance

Debt Settlement Biopharmaceutical Regulatory Approval Share Issuance Therapeutic Development
PRESS RELEASE

published on 06/02/2026 at 04:00, 15 days 23 hours ago

Lobe Sciences Announces Proposed Shares for Debt Transaction
Lobe Sciences announces agreement to settle outstanding management and director fee debt through issuance of common shares. Debt Settlement subject to regulatory approvals

Management Regulatory Approvals Settlement Shares Lobe Sciences Director Fee Debt
BRIEF

published on 05/07/2026 at 02:05, 1 month 11 days ago

Lobe Sciences Ltd. to Attend D. Boral Capital Global Conference

Drug Development Biopharmaceutical Global Conference Sickle Cell Disease Psilocin
PRESS RELEASE

published on 05/07/2026 at 02:00, 1 month 11 days ago

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Lobe Sciences Ltd. announces CEO participation in D. Boral Capital Global Conference to discuss therapeutic programs and drug candidates

Clinical-Stage Biopharmaceutical Drug Candidates Lobe Sciences Ltd. Therapeutic Programs D. Boral Capital Global Conference
BRIEF

published on 05/06/2026 at 12:05, 1 month 11 days ago

Lobe Sciences Reports Q2 2026 Financials and Operational Progress

Private Placement Financial Results Drug Development Net Loss R&D Investment
PRESS RELEASE

published on 05/06/2026 at 12:00, 1 month 11 days ago

Lobe Sciences Reports Second Quarter 2026 Results and Highlights Continued Operational Progress
Lobe Sciences Ltd. released unaudited financial results for Q2 2026, showing progress in R&D expenses, operating cash flow, and net loss. CEO emphasizes advancing core programs and maintaining shareholder value

Financial Results Operating Cash Flow Net Loss R&D Expenses Lobe Sciences Ltd.
BRIEF

published on 04/23/2026 at 14:05, 1 month 24 days ago

Lobe Sciences Welcomes White House Order on Neurological Drug Development

Drug Development Neurological Disorders Research Expansion Executive Order Lobe Sciences
PRESS RELEASE

published on 04/23/2026 at 14:00, 1 month 24 days ago

Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
Lobe Sciences welcomes White House Executive Order supporting advancements in neurology and mental health treatments, focusing on scientific research and compound evaluation

Mental Health Neurology Thérapies Lobe Sciences White House Executive Order

1 2 ... 6

Accesswire

Published on 06/18/2026 at 00:00, 3 hours 40 minutes ago

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 4 hours 10 minutes ago

Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 4 hours 50 minutes ago

International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 5 hours 10 minutes ago

Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 10 hours 45 minutes ago

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 02:45, 55 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Update on APAC matter
Published on 06/17/2026 at 21:40, 6 hours ago

Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 19:10, 8 hours 30 minutes ago

Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:40, 9 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2026 at 18:36, 9 hours 4 minutes ago

BILENDI: Bilendi announces that Euroland Corporate has initiated coverage of its shares

Les Echos

Published on 06/17/2026 at 17:40, 10 hours ago

Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 18 hours 55 minutes ago

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 15 hours ago

Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 4 hours ago

BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 8 hours ago

Reporting on share buyback transactions carried out between June 8 and June 11, 2026

View all LES ECHOS COMFI WIRE